Pasireotide in the Treatment of Hypoglycemia Following Gastric Bypass Surgery

NCT03514576 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Hypoglycemia, Reactive

Interventions

DRUG: Pasireotide 0.3 MG/ML
DIAGNOSTIC_TEST: Meal tolerance test (MTT)

Sponsor

Zealand University Hospital